Business / Finance

RSS

Thrasos completes $35 Million financing for development of THR-184 against AKI

Thrasos Therapeutics announced that it has completed a $35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI).

25 Oct 2012

DSM extends license to supply CarboSil® TSPCU for use in AxioMed Spine Corporation’s Freedom® Spinal Discs

DSM, a global leader in biomedical materials sciences, and AxioMed Spine Corporation, an innovator in the field of spinal implant devices, today announced that they have revised and extended an existing licensing and supply agreement. DSM will supply its proprietary CarboSil®Thermoplastic Silicone-Polycarbonate-urethane material for use in AxioMed’s Freedom® Lumbar and Freedom® Cervical Discs.

24 Oct 2012

ZOLL Medical announces new Tokyo-based subsidiary

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions and a wholly owned U.S. subsidiary of Asahi Kasei, has established Asahi Kasei ZOLL Medical Corporation (AZM) as its Japanese subsidiary effective November 5.

24 Oct 2012

Financial environment presents opportunities as well as challenges

Leading biotechnology executive Dr Deborah Rathjen has called on the industry to look at the opportunities that exist in a post-GFC environment, not just to focus on the negatives.

23 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

Lantheus Medical Imaging extends contract to supply molybdenum-99 to Nordion

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.

22 Oct 2012

Two leading health systems announce plan to merge

Trinity Health and Catholic Health East plan to consolidate operations. Together, the two systems will span 21 states and include more than 70 hospitals.

19 Oct 2012

Wolters Kluwer Health enters agreement to acquire Health Language

Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, announced today that it has entered into an agreement to acquire Health Language, Inc., a leader in Medical Terminology Management (MTM), a rapidly growing segment of the point-of-care market.

17 Oct 2012

UnitedHealth's profit jumps 23 percent in third quarter

The raised profit forecast for the nation's largest insurer was attributed to big enrollment boosts in the company's Medicare and Medicaid plans, even as medical costs remained stable despite an improved economy.

17 Oct 2012

Hillenbrand enters definitive agreement to acquire Coperion

Hillenbrand, Inc. has entered into a definitive agreement to acquire privately held Coperion Capital, a portfolio company of Deutsche Beteiligungs AG, for an estimated purchase price of €408 million ($530 million at current exchange rates), which includes the assumption of an estimated €76 million of net debt and €100 million pension liability.

16 Oct 2012

FTC votes to approve Watson's acquisition of Actavis

Watson Pharmaceuticals, Inc. today announced that the Federal Trade Commission (FTC) has voted to approve Watson's acquisition of the Actavis group of companies.

16 Oct 2012

Wise Foundation announces name change

The Wise Foundation has announced the transition to its new name, the Association for Vascular Access (AVA) Foundation. The new name better emphasizes the organization's bond with its parent organization, the Association for Vascular Access.

16 Oct 2012

Taking technology from the lab to the patient: SMART Arm™: Hand of hope for stroke survivors

Creating a viable commercial product from its beginnings as a research concept through to a final product patients can use is a long, difficult and often expensive process. However, as David Henderson, the Managing Director of UniQuest, one of the leading technology transfer companies in the Asia Pacific region explains, a focus on patient needs is vital for developing a successful product.

15 Oct 2012

Critical Diagnostics signs agreements with four new European distributors

Critical Diagnostics, a U.S.-based biomarker company focused on cardiovascular diseases, today announced that it has signed agreements with four new European distributors in Germany, Spain, France and Turkey.

15 Oct 2012

KYTHERA prices initial public offering of 4,400,000 shares of common stock

KYTHERA Biopharmaceuticals, Inc. today announced the pricing of its initial public offering of 4,400,000 shares of its common stock at a price to the public of $16.00 per share.

11 Oct 2012

Theragenics enters second amended and restated credit agreement with Wells Fargo

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has entered into a Second Amended and Restated Credit Agreement with Wells Fargo Bank, National Association.

11 Oct 2012

Beekman closes sale of Northwestern Management Services

The Beekman Group announced the closing of the sale of Northwestern Management Services, LLC to Linden Capital Partners, a leading healthcare-focused middle market investment firm.

11 Oct 2012

Genocea raises $30M in Series C financing round

Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $30 million in a Series C financing round.

10 Oct 2012

Biomet first quarter net sales increase 6% to $707.4 million

Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2012.

10 Oct 2012

Boston Scientific enters definitive agreement to acquire Rhythmia Medical

Boston Scientific Corporation has entered into a definitive agreement to acquire privately-held Rhythmia Medical, Inc., a developer of next-generation mapping and navigation solutions for use in cardiac catheter ablations and other electrophysiology procedures, including atrial fibrillation and atrial flutter.

9 Oct 2012